Feb 15 (Reuters) - Memphasys Ltd (MEM) - Statutory demand issued by Prime Biologics Pte Ltd against Memphasys limited has been agreed to be set aside by mutual consent of parties
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint